Table 4.

Self-reported Osteoarthritis Treatments Initiated During the Study Period^*

Treatment	Usual Care (n = 129)	Patient Intervention (n = 128)	Provider Intervention (n = 140)	Patient-Provider Intervention (n = 140)
Physical therapy	9 (8.4)	12 (12.5)	16 (13.1)	9 (9.1)
Knee osteoarthritis†	7 (7.1)	12 (14.0)	13 (11.3)	7 (7.6)
Hip osteoarthritis‡	2 (10.5)	0 (0)	3 (21.4)	2 (12.5)
Knee brace
Any§	6 (5.8)	8 (8.6)	7 (6.0)	8 (8.0)
Metal||	0 (0)	1 (1.2)	2 (1.8)	0 (0)
Joint injection||	19 (18.5)	22 (23.7)	27 (22.9)	17 (16.7)
Topical NSAID or capsaicin¶	7 (5.7)	8 (7.1)	10 (7.6)	8 (6.6)
New pain medication**	32 (28.8)	27 (27.8)	41 (33.1)	40 (38.8)
Joint replacement surgery	4 (3.1)	5 (3.9)	3 (2.1)	5 (3.6)

NSAID = nonsteroidal anti-inflammatory drug.

^*Values are numbers (percentages). Treatments specific to knee or hip osteoarthritis were calculated only among patients diagnosed with either of these conditions at the medical chart review. All osteoarthritis treatment data from the 12-mo visit are missing for 102 patients (18 in the usual care group, 31 in the patient group, 16 in the provider group, and 37 in the patient-provider group).

^†Data are missing for 18 patients.

^‡Data are missing for 1 patient.

^§Data are missing for 12 patients.

^||Data are missing for 19 patients.

^¶Defined as self-report of using a topical NSAID or capsaicin at 12-mo follow-up but not at baseline. Data on new use of topical therapy are missing for 47 patients.

^**Change in pain medication was defined as self-report of using a pain medication for osteoarthritis at 12-mo follow-up but not at baseline or self-report of using a different pain medication at 12-mo follow-up than at baseline.